Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep 15;128(18):3418-3419.
doi: 10.1002/cncr.34382. Epub 2022 Jul 8.

Reply to "The use of national datasets to evaluate outcomes for invasive lobular carcinoma"

Roi Weiser  1 , Efstathia Polychronopoulou  2 , V Suzanne Klimberg  1   3
Affiliations
Free article
Comment

Reply to "The use of national datasets to evaluate outcomes for invasive lobular carcinoma"

Roi Weiser et al. Cancer. .
Free article
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Weiser R, Polychronopoulou E, Hatch SS, et al. Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: a National Cancer Database analysis. Cancer. 2022;128(9):1738-1747. doi:10.1002/cncr.34127
    1. Kizy S, Altman AM, Marmor S, et al. 21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer. J Geriatr Oncol. 2019;10(2):322-329. doi:10.1016/j.jgo.2018.07.006
    1. Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24(23):3726-3734. doi:10.1200/jco.2005.04.7985
    1. Albain KS, Barlow WE, Shak S, et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol. 2010;11(1):55-65. doi:10.1016/s1470-2045(09)70314-6
    1. Jenkins JA, Marmor S, Hui JYC, et al. The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer. Breast Cancer Res Treat. 2022;191(2):401-407. doi:10.1007/s10549-021-06429-8

LinkOut - more resources